Post-transplant lymphoproliferative disease

Common Name(s)

Post-transplant lymphoproliferative disease

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Post-transplant lymphoproliferative disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Post-transplant lymphoproliferative disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Post-transplant lymphoproliferative disease" returned 25 free, full-text research articles on human participants. First 3 results:

How Should We Treat Early Post-Transplant Lymphoproliferative Disease After Heart Transplantation?
 

Author(s): Daisuke Nitta, Koichiro Kinugawa, Teruhiko Imamura, Masaru Hatano, Minoru Ono, Fumihiko Nakamura, Mineo Kurokawa, Issei Komuro

Journal: Int Heart J. 2015 ;56(6):676-8.

 

Although post-transplant lymphoproliferative disease (PTLD) is one of the major fatal complications encountered several years after heart transplant (HTx), little is known about early-PTLD emerging within the first year. We here describe the rare case of a 24-year-old female patient ...

Last Updated: 3 Dec 2015

Go To URL
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey.
 

Author(s): R San-Juan, O Manuel, H H Hirsch, M Fernández-Ruiz, F López-Medrano, P Comoli, S Caillard, P Grossi, J M Aguado, ,

Journal: Clin. Microbiol. Infect.. 2015 Jun;21(6):604.e1-9.

 

There is limited clinical evidence on the utility of the monitoring of Epstein-Barr virus (EBV) DNAemia in the pre-emptive management of post-transplant lymphoproliferative disease (PTLD) in solid organ transplant (SOT) recipients. We investigated current preventive measures against ...

Last Updated: 16 Jun 2015

Go To URL
Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients.
 

Author(s): Heloisa Helena de Sousa Marques, Maria Aparecida Shikanai-Yasuda, Luiz Sérgio Fonseca de dAzevedo, Hélio Helh Caiaffa-Filho, Lígia Camera Pierrotti, Maria Zilda de Aquino, Marta Heloisa Lopes, Natalya Zaidan Maluf, Silvia Vidal Campos, Silvia Figueiredo Costa

Journal: Rev. Soc. Bras. Med. Trop.. ;47(5):543-6.

 

Epstein-Barr virus (EBV)-related post-transplant lymphoproliferative disease (PTLD) is one of the most serious complications associated with solid organ and hematopoietic stem cell transplantation. PTLD is most frequently seen with primary EBV infection post-transplant, a common scenario ...

Last Updated: 3 Dec 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Post-transplant lymphoproliferative disease" returned 4 free, full-text review articles on human participants. First 3 results:

Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.
 

Author(s): Zeina Al-Mansour, Beverly P Nelson, Andrew M Evens

Journal: Curr Hematol Malig Rep. 2013 Sep;8(3):173-83.

 

Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate solid organ or hematopoietic transplantation. Risk factors for PTLD include viral infections, degree of ...

Last Updated: 2 Sep 2013

Go To URL
T-cell therapy in the treatment of post-transplant lymphoproliferative disease.
 

Author(s): Catherine M Bollard, Cliona M Rooney, Helen E Heslop

Journal: Nat Rev Clin Oncol. 2012 Sep;9(9):510-9.

 

Post-transplant lymphoproliferative diseases (PTLD) associated with Epstein-Barr virus (EBV) infection often develop after organ and haematopoietic stem-cell transplantation. These lymphoproliferative diseases are tumours that usually express all latent EBV viral proteins, and are ...

Last Updated: 29 Aug 2012

Go To URL
Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?
 

Author(s): Krzysztof Mucha, Bartosz Foroncewicz, Bogna Ziarkiewicz-Wróblewska, Marek Krawczyk, Jan Lerut, Leszek Paczek

Journal: Nephrol. Dial. Transplant.. 2010 Jul;25(7):2089-98.

 

Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of solid-organ transplantation (SOT) and bone marrow transplantation leading to a high mortality (30-60%). PTLD represents a heterogeneous group of lymphoproliferative diseases. They ...

Last Updated: 25 Jun 2010

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy
 

Status: Recruiting

Condition Summary: Posttransplant Lymphoproliferative Disorder

 

Last Updated: 3 Aug 2015

Go to URL
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
 

Status: Recruiting

Condition Summary: Heart Transplant; Small Intestine Transplant; Kidney Transplant; Liver Transplant; Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder; PTLDs

 

Last Updated: 20 Apr 2016

Go to URL
Transfusion-related EBV Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients
 

Status: Recruiting

Condition Summary: Lymphoproliferative Disorders

 

Last Updated: 20 Jul 2015

Go to URL